CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Camalexin 5mg  | ≥99%

CSNpharm

Camalexin is a phytoalexin isolated from cruciferous plants that exhibits antibacterial, antifungal, antiproliferative and cancer chemopreventive activities and increases the ROS levels.

More Information Supplier Page

Camalexin 50mg  | ≥99%

CSNpharm

Camalexin is a phytoalexin isolated from cruciferous plants that exhibits antibacterial, antifungal, antiproliferative and cancer chemopreventive activities and increases the ROS levels.

More Information Supplier Page

Camalexin 10mg  | ≥99%

CSNpharm

Camalexin is a phytoalexin isolated from cruciferous plants that exhibits antibacterial, antifungal, antiproliferative and cancer chemopreventive activities and increases the ROS levels.

More Information Supplier Page

Camalexin 25mg  | ≥99%

CSNpharm

Camalexin is a phytoalexin isolated from cruciferous plants that exhibits antibacterial, antifungal, antiproliferative and cancer chemopreventive activities and increases the ROS levels.

More Information Supplier Page

Camostat Mesilate 10mg  | ≥99%

CSNpharm

Camostat mesylate is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trypsin, prostasin and matriptase. Also it inhibits transmembrane serine protease TMPRSS2, suggesting that it could block entry of SARS-Cov-2 (COVID-19) into lung cells in vitro.

More Information Supplier Page

Camostat Mesilate 50mg  | ≥99%

CSNpharm

Camostat mesylate is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trypsin, prostasin and matriptase. Also it inhibits transmembrane serine protease TMPRSS2, suggesting that it could block entry of SARS-Cov-2 (COVID-19) into lung cells in vitro.

More Information Supplier Page

Camostat Mesilate 100mg  | ≥99%

CSNpharm

Camostat mesylate is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trypsin, prostasin and matriptase. Also it inhibits transmembrane serine protease TMPRSS2, suggesting that it could block entry of SARS-Cov-2 (COVID-19) into lung cells in vitro.

More Information Supplier Page

Campathecin 100mg  | ≥99%

CSNpharm

Camptothecin is a potent DNA enzyme topoisomerase I (topo I) inhibitor with an IC50 and IC70 of 50 nM and 0.225 μM for breast cancer cell line MDA-MB-231.

More Information Supplier Page

Canertinib 5mg  | ≥99%

CSNpharm

Canertinib is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.

More Information Supplier Page

Canertinib 100mg  | ≥99%

CSNpharm

Canertinib is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.

More Information Supplier Page

Canertinib 50mg  | ≥99%

CSNpharm

Canertinib is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.

More Information Supplier Page

Canertinib 250mg  | ≥99%

CSNpharm

Canertinib is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.

More Information Supplier Page

Canertinib 10mg  | ≥99%

CSNpharm

Canertinib is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4.

More Information Supplier Page

Canertinib 2HCl 250mg  | ≥99%

CSNpharm

Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.

More Information Supplier Page

Canertinib 2HCl 5mg  | ≥99%

CSNpharm

Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.

More Information Supplier Page

Canertinib 2HCl 10mg  | ≥99%

CSNpharm

Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.

More Information Supplier Page

Canertinib 2HCl 100mg  | ≥99%

CSNpharm

Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.

More Information Supplier Page

Canertinib 2HCl 50mg  | ≥99%

CSNpharm

Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.

More Information Supplier Page

Capecitabine 1g  | ≥99%

CSNpharm

Capecitabine is a tumor-selective fluoropyrimidine carbamate, which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU, and used as an anti-cancer prodrug.

More Information Supplier Page

Capreomycin Sulfate 5g  | ≥99%

CSNpharm

Capreomycin Sulfate is a polypeptide antibiotic obtained from Streptomyces capreolus, which can inhibit bacterial protein synthesis by binding to 30S and 50S ribosomal subunits. It has emerged as the first-line injectable agent in regimens for the treatment of drug-resistant tuberculosis.

More Information Supplier Page

Capreomycin Sulfate 250mg  | ≥99%

CSNpharm

Capreomycin Sulfate is a polypeptide antibiotic obtained from Streptomyces capreolus, which can inhibit bacterial protein synthesis by binding to 30S and 50S ribosomal subunits. It has emerged as the first-line injectable agent in regimens for the treatment of drug-resistant tuberculosis.

More Information Supplier Page

Capreomycin Sulfate 1g  | ≥99%

CSNpharm

Capreomycin Sulfate is a polypeptide antibiotic obtained from Streptomyces capreolus, which can inhibit bacterial protein synthesis by binding to 30S and 50S ribosomal subunits. It has emerged as the first-line injectable agent in regimens for the treatment of drug-resistant tuberculosis.

More Information Supplier Page

Capsazepine 100mg  | ≥98%

CSNpharm

Capsazepine is an antagonist of TRPV1 receptor with IC50 of 562 nM. It is synthetic analogue of sensory neurone excitotoxin.

More Information Supplier Page

Capsazepine 5mg  | ≥98%

CSNpharm

Capsazepine is an antagonist of TRPV1 receptor with IC50 of 562 nM. It is synthetic analogue of sensory neurone excitotoxin.

More Information Supplier Page

Capsazepine 50mg  | ≥98%

CSNpharm

Capsazepine is an antagonist of TRPV1 receptor with IC50 of 562 nM. It is synthetic analogue of sensory neurone excitotoxin.

More Information Supplier Page

Capsazepine 10mg  | ≥98%

CSNpharm

Capsazepine is an antagonist of TRPV1 receptor with IC50 of 562 nM. It is synthetic analogue of sensory neurone excitotoxin.

More Information Supplier Page

Carbamazepine 100mg  | ≥99%

CSNpharm

Carbamazepine is a blocker of sodium channel with IC50 of 131 μM in rat brain synaptosomes. It is an anticonvulsant drug.

More Information Supplier Page

Carbamazepine 25mg  | ≥99%

CSNpharm

Carbamazepine is a blocker of sodium channel with IC50 of 131 μM in rat brain synaptosomes. It is an anticonvulsant drug.

More Information Supplier Page

Carbenicillin Disodium 1g  | Purity Not Available

CSNpharm

Carbenicillin disodium is a semi-synthetic penicillin antibiotic which interferes with cell wall synthesis of Gram-negative bacteria while displaying low toxicity.

More Information Supplier Page

Carbenicillin Disodium 5g  | Purity Not Available

CSNpharm

Carbenicillin disodium is a semi-synthetic penicillin antibiotic which interferes with cell wall synthesis of Gram-negative bacteria while displaying low toxicity.

More Information Supplier Page